Growth Metrics

Carlsmed (CARL) Equity Ratio (2024 - 2026)

Carlsmed filings provide 2 years of Equity Ratio readings, the most recent being 0.76 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 155.75% to 0.76 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.76, a 155.75% increase, with the full-year FY2025 number at 0.76, up 155.75% from a year prior.
  • Equity Ratio hit 0.76 in Q4 2025 for Carlsmed, down from 0.79 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.79 in Q3 2025 to a low of 1.56 in Q2 2025.